Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
Buy
54
HQY Quote, Financials, Valuation and Earnings
Last price:
$83.41
Seasonality move
:
12.82%
Day range:
$81.23 - $83.62
52-week range:
$65.01 - $115.59
Dividend yield:
0%
P/E ratio:
76.56x
P/S ratio:
6.17x
P/B ratio:
3.41x
Volume:
943.4K
Avg. volume:
1.4M
1-year change:
2.78%
Market cap:
$7.2B
Revenue:
$1.2B
EPS (TTM):
$1.09
Analysts' Opinion
-
Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $110.93, HealthEquity has an estimated upside of 32.93% from its current price of $83.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $94.00 representing 100% downside risk from its current price of $83.45.
Fair Value
-
According to the consensus of 10 analysts, HealthEquity has 32.93% upside to fair value with a price target of $110.93 per share.
HQY vs. S&P 500
-
Over the past 5 trading days, HealthEquity has overperformed the S&P 500 by 0.01% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
HealthEquity does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthEquity has grown year-over-year revenues for 15 quarters straight. In the most recent quarter HealthEquity reported revenues of $311.8M.
Earnings Growth
-
HealthEquity has grown year-over-year earnings for 0 quarters straight. In the most recent quarter HealthEquity reported earnings per share of $0.30.
Enterprise value:
8B
EV / Invested capital:
2.52x
Price / LTM sales:
6.17x
EV / EBIT:
45.16x
EV / Revenue:
6.65x
PEG ratio (5yr expected):
1.09x
EV / Free cash flow:
-48.18x
Price / Operating cash flow:
35.43x
Enterprise value / EBITDA:
23.53x
Gross Profit (TTM):
$777.3M
Return On Assets:
2.87%
Net Income Margin (TTM):
8.06%
Return On Equity:
4.59%
Return On Invested Capital:
3.11%
Operating Margin:
14.22%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $861.7M | $999.6M | $1.2B | $262.4M | $311.8M | |
| Gross Profit | $491.9M | $622.6M | $777.3M | $163.3M | $189M | |
| Operating Income | $37.7M | $128.1M | $202.9M | $41.2M | $44.3M | |
| EBITDA | $171.5M | $283.6M | $339.1M | $81.3M | $84.4M | |
| Diluted EPS | -$0.31 | $0.64 | $1.09 | $0.30 | $0.30 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $460.2M | $351.3M | $382.9M | $557.4M | $477.7M | |
| Total Assets | $2.7B | $3.1B | $3.1B | $3.2B | $3.4B | |
| Current Liabilities | $204.7M | $153.2M | $131.1M | $117.1M | $156.3M | |
| Total Liabilities | $1.3B | $1.3B | $1.2B | $1.1B | $1.3B | |
| Total Equity | $1.4B | $1.9B | $1.9B | $2B | $2.1B | |
| Total Debt | $986.7M | $930.8M | $925.3M | $875M | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $150.7M | $242.8M | $339.9M | $77.1M | $75.7M | |
| Cash From Investing | -$119.1M | -$46.1M | -$505.5M | -$11.3M | -$13.6M | |
| Cash From Financing | -$2.7M | -$47M | $57.6M | $4.1M | -$88.4M | |
| Free Cash Flow | $31.5M | $196.8M | -$165.6M | $65.8M | $62.2M | |
HQY
Sector
Market Cap
$7.2B
$34.9M
Price % of 52-Week High
72.2%
42.85%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
2.78%
-40.42%
Beta (5-Year)
0.487
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$82.40
200-day SMA
Sell
Level
$90.01
Bollinger Bands (100)
Sell
Level
88.68 - 108.14
Chaikin Money Flow
Buy
Level
84.3M
20-day SMA
Sell
Level
$84.03
Relative Strength Index (RSI14)
Sell
Level
45.09
ADX Line
Sell
Level
33.37
Williams %R
Neutral
Level
-36.92
50-day SMA
Sell
Level
$95.80
MACD (12, 26)
Sell
Level
-3.47
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
109.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.0127)
Buy
CA Score
(Annual)
Level (0.5036)
Buy
Beneish M-Score
(Annual)
Level (-2.7368)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.3045)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Stock Forecast FAQ
In the current month, HQY has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HQY average analyst price target in the past 3 months is $110.93.
-
Where Will HealthEquity Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthEquity share price will rise to $110.93 per share over the next 12 months.
-
What Do Analysts Say About HealthEquity?
Analysts are divided on their view about HealthEquity share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthEquity is a Sell and believe this share price will drop from its current level to $94.00.
-
What Is HealthEquity's Price Target?
The price target for HealthEquity over the next 1-year time period is forecast to be $110.93 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HQY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthEquity is a Buy. 9 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HQY?
You can purchase shares of HealthEquity via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthEquity shares.
-
What Is The HealthEquity Share Price Today?
HealthEquity was last trading at $83.41 per share. This represents the most recent stock quote for HealthEquity. Yesterday, HealthEquity closed at $83.45 per share.
-
How To Buy HealthEquity Stock Online?
In order to purchase HealthEquity stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 9.85% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 3.55% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is up 1.99% over the past day.
